Susceptibility of influenza B viruses to neuraminidase inhibitors: findings from the first 4 years (2008–2012) of the global Influenza Resistance Information Study (IRIS) [PDF]
Poster Session: Antiviral Drugs and ResistanceBackground: Type B influenza virus infections continue to account for a substantial proportion of clinical illness. Little is known about comparative disease profiles by virus lineage.
Boucher, CA +5 more
core
Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection. [PDF]
Fujita Y +5 more
europepmc +1 more source
Effectiveness of oseltamivir in hospitalised obstetric patients with COVID-19: a retrospective cohort study using a Brazilian national database. [PDF]
Burvill A +3 more
europepmc +1 more source
A cost-effectiveness analysis of baloxavir marboxil versus oseltamivir for seasonal influenza treatment in China. [PDF]
Zheng F, Tang Y, Jiang H.
europepmc +1 more source
A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance. [PDF]
Zhang L +11 more
europepmc +1 more source
Afebrile Presentation in COPD Patients with Influenza A: A Risk Factor for Prolonged Viral Shedding. [PDF]
Fan Y +6 more
europepmc +1 more source
Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data. [PDF]
Ji Y, Yang W, Wang W.
europepmc +1 more source
Efficacy and Safety of Anti-Influenza Drugs in 160 Chinese Children With Influenza A: A Retrospective Study. [PDF]
Li W +8 more
europepmc +1 more source

